134 related articles for article (PubMed ID: 2345633)
1. [Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)].
Müzes G; Deák G; Láng I; Nékám K; Niederland V; Fehér J
Orv Hetil; 1990 Apr; 131(16):863-6. PubMed ID: 2345633
[TBL] [Abstract][Full Text] [Related]
2. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
[TBL] [Abstract][Full Text] [Related]
3. [Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases].
Deák G; Müzes G; Láng I; Niederland V; Nékám K; Gonzalez-Cabello R; Gergely P; Fehér J
Orv Hetil; 1990 Jun; 131(24):1291-2, 1295-6. PubMed ID: 2195425
[TBL] [Abstract][Full Text] [Related]
4. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
Fehér J; Deák G; Müzes G; Láng I; Niederland V; Nékám K; Kárteszi M
Orv Hetil; 1989 Dec; 130(51):2723-7. PubMed ID: 2574842
[TBL] [Abstract][Full Text] [Related]
5. Effect of the natural bioflavonoid antioxidant silymarin on superoxide dismutase (SOD) activity and expression in vitro.
Láng I; Deák G; Müzes G; Prónai L; Fehér J
Biotechnol Ther; 1993; 4(3-4):263-70. PubMed ID: 8292974
[TBL] [Abstract][Full Text] [Related]
6. In vivo effect of free radical scavenger hepatoprotective agents on superoxide dismutase (SOD) activity in patients.
Fehér J; Láng I; Nékám K; Gergely P; Mũzes G
Tokai J Exp Clin Med; 1990 May; 15(2-3):129-34. PubMed ID: 2130521
[TBL] [Abstract][Full Text] [Related]
7. Effect of the bioflavonoid silymarin on the in vitro activity and expression of superoxide dismutase (SOD) enzyme.
Müzes G; Deák G; Láng I; Nékám K; Gergely P; Fehér J
Acta Physiol Hung; 1991; 78(1):3-9. PubMed ID: 1763650
[TBL] [Abstract][Full Text] [Related]
8. Effect of free radical scavengers on superoxide dismutase (SOD) enzyme in patients with alcoholic cirrhosis.
Fehér J; Láng I; Nékám K; Müzes G; Deák G
Acta Med Hung; 1988; 45(3-4):265-76. PubMed ID: 3249654
[TBL] [Abstract][Full Text] [Related]
9. The effect of silibinin (Legalon) on the the free radical scavenger mechanisms of human erythrocytes in vitro.
Altorjay I; Dalmi L; Sári B; Imre S; Balla G
Acta Physiol Hung; 1992; 80(1-4):375-80. PubMed ID: 1345204
[TBL] [Abstract][Full Text] [Related]
10. Free radicals in tissue damage in liver diseases and therapeutic approach.
Fehér J; Láng I; Deák G; Cornides A; Nékám K; Gergely P
Tokai J Exp Clin Med; 1986; 11 Suppl():121-34. PubMed ID: 3452238
[TBL] [Abstract][Full Text] [Related]
11. Effect of silibinin on the activity and expression of superoxide dismutase in lymphocytes from patients with chronic alcoholic liver disease.
Fehér J; Láng I; Nékám K; Csomós G; Müzes G; Deák G
Free Radic Res Commun; 1987; 3(6):373-7. PubMed ID: 3508451
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of silymarin on erythrocyte haemolysate against benzo(a)pyrene and exogenous reactive oxygen species (H2O2) induced oxidative stress.
Kiruthiga PV; Shafreen RB; Pandian SK; Arun S; Govindu S; Devi KP
Chemosphere; 2007 Jul; 68(8):1511-8. PubMed ID: 17481694
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients].
Trinchet JC; Coste T; Lévy VG; Vivet F; Duchatelle V; Legendre C; Gotheil C; Beaugrand M
Gastroenterol Clin Biol; 1989; 13(2):120-4. PubMed ID: 2707520
[TBL] [Abstract][Full Text] [Related]
14. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.
Gharagozloo M; Moayedi B; Zakerinia M; Hamidi M; Karimi M; Maracy M; Amirghofran Z
Fundam Clin Pharmacol; 2009 Jun; 23(3):359-65. PubMed ID: 19453758
[TBL] [Abstract][Full Text] [Related]
15. [Controlled study of the effect of silymarin on alcoholic liver disease].
Bunout D; Hirsch S; Petermann M; de la Maza MP; Silva G; Kelly M; Ugarte G; Iturriaga H
Rev Med Chil; 1992 Dec; 120(12):1370-5. PubMed ID: 1343377
[TBL] [Abstract][Full Text] [Related]
16. Hepatoprotective effect of chrysin on prooxidant-antioxidant status during ethanol-induced toxicity in female albino rats.
Sathiavelu J; Senapathy GJ; Devaraj R; Namasivayam N
J Pharm Pharmacol; 2009 Jun; 61(6):809-17. PubMed ID: 19505373
[TBL] [Abstract][Full Text] [Related]
17. Short term treatment of type II hyperlipoproteinaemia with silymarin.
Somogyi A; Ecsedi GG; Blázovics A; Miskolczi K; Gergely P; Fehér J
Acta Med Hung; 1989; 46(4):289-95. PubMed ID: 2699920
[TBL] [Abstract][Full Text] [Related]
18. Hepatoprotective and immunological effects of antioxidant drugs.
Láng I; Nékám K; González-Cabello R; Mũzes G; Gergely P; Fehér J
Tokai J Exp Clin Med; 1990 May; 15(2-3):123-7. PubMed ID: 1983370
[TBL] [Abstract][Full Text] [Related]
19. The anti-fatty liver effects of garlic oil on acute ethanol-exposed mice.
Zeng T; Guo FF; Zhang CL; Zhao S; Dou DD; Gao XC; Xie KQ
Chem Biol Interact; 2008 Nov; 176(2-3):234-42. PubMed ID: 18718457
[TBL] [Abstract][Full Text] [Related]
20. Hepatoprotective and immunomodulatory effects of antioxidant therapy.
Láng I; Deák G; Nékám K; Müzes G; González-Cabello R; Gergely P; Fehér J
Acta Med Hung; 1988; 45(3-4):287-95. PubMed ID: 3074277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
